Researchers at the University of Alabama at Birmingham have discovered a way to prevent kidney failure from occurring in people with multiple...
Myeloma NZ
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.
The treatment landscape for multiple myeloma has dramatically changed over the past decade with the introduction of several new classes of drugs,...
JOIN THE MARCH
For those who are able to, including family and friends, we urge you to join us on Tuesday 7 May in Wellington to march for the RIGHT TO LIVE. We'll...
Toward personalized treatment in multiple myeloma based on molecular characteristics.
To date, the choice of therapy for an individual multiple myeloma patient has been based on clinical factors such as age and comorbidities. The...
Newsletter: April 2019
Greetings to everyone as the days draw in. We are intending to generate some heat with various planned activities over the next month. There has...
Patient Seminar with Prof. Nikhil C. Munshi: Minimal residual disease in Myeloma sessions
https://vimeo.com/330610777 https://vimeo.com/330611169
Imaging in multiple myeloma: How? When?
Bone disease is the most frequent feature of multiple myeloma (MM) and represents a marker of end-organ damage; it is used to establish the...
Multiple Myeloma Research Review
Highlights include: Real-life safety and efficacy of autologous SCT in elderly MM Lenalidomide maintenance vs. observation for newly diagnosed MM...
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised,...
Going the distance: Are we losing patients along the multiple myeloma treatment pathway?
Despite data suggesting that individuals with multiple myeloma can benefit from receiving several lines of therapy, and guidelines recommending...
Single-cell Profiling in Multiple Myeloma May Improve Diagnosis, Treatment, Study Suggests
Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic,...
Lenalidomide Maintenance Therapy for Multiple Myeloma
Orally administered lenalidomide, a second-generation antimyeloma thalidomide analog, is a workhorse in contemporary management of multiple myeloma:...